Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by leonenoelon May 26, 2021 9:25pm
210 Views
Post# 33273291

RE:GE healthcare and reconstruction with AI

RE:GE healthcare and reconstruction with AI

Hi Graham,
Thanks for sharing your dd. If facing open heart surgery, who wouldn't want the best scan even if it meant only 1% more accuracy?  MRIs will always be in cardiologists' toolkit. If I'm going for a regular checkup and a VMS can give me accurate info needed in 5 minutes vs 45-60 minutes in regular echo suite or longer in a MRI, I'll take the VMS.  That's just me.

In January 2000 I had heart surgery to replace my tricuspid valve and I was presented the option to correct my other congenital defect through reconstruction. I seriously considered the option and declined, however if presented with VMS vs MRI for reconstruction today, I would choose MRI.

I'm saying that there is room for both tools in this field, both have pros/cons such as time, money, high-res, etc.  The industry needs both and VMS seems to be an excellent choice for day to day diagnosis that can help a cardiologist decide if a MRI is warranted. 

GrahamB wrote:

Was researching on artificial intelligence and cardiac imaging and looked for updates on the GE Edison website. There was some pretty interesting information on the impressive improvements in image quality and in  resolution that were made possible using deep learning image reconstruction techniques.

I didn't see anything on VPT or on echo-but maybe some information is coming?

So far MRI is still the leading method recommended by Cardiologists as outlined on the GE website.

'Great news for patients though that reconstruction with AI is gaining traction.

 

https://www.gehealthcare.com/article/advancing-cardiac-magnetic-resonance-imaging-with-deep-learning-image-reconstruction

 



<< Previous
Bullboard Posts
Next >>